(84 days)
No
The summary describes a software package for 3D reconstruction of 2D X-ray images. It mentions image processing but does not mention AI, DNN, or ML, nor does it provide details about training or test sets which are typical for AI/ML devices. The focus is on image reconstruction, not interpretation or analysis using AI/ML.
No
The device is described as x-ray imaging software intended for diagnosis, surgical planning, interventional procedures, and treatment follow-up. It does not actively treat or directly interact with the body for therapeutic purposes.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is intended "for diagnosis, surgical planning, interventional procedures and treatment follow-up" and will "assist the physician in diagnosis."
Yes
The device is explicitly described as a "software option" that performs reconstruction of images acquired by a separate hardware device (a standard angiographic C-arm). The description focuses solely on the software's function and does not mention any accompanying hardware components or hardware-specific validation.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The In Space 3D package is a software option that processes x-ray images acquired from a standard angiographic C-arm device. It reconstructs 2D images into a 3D format for visualization and analysis.
- Intended Use: The intended use is for imaging and assisting physicians in diagnosis, surgical planning, interventional procedures, and treatment follow-up based on these imaging data, not on analysis of biological samples.
The device deals with in vivo imaging data (images of the inside of the body), not in vitro (outside the body) analysis of biological samples.
N/A
Intended Use / Indications for Use
The In Space 3D package is a x-ray imaging software option which allows the reconstruction of two-dimensional images acquired with a standard angiographic C-arm device into a three-dimensional image format.
The In Space 3D package is intended for imaging both hard and soft tissues as well as other internal body structures(eg. Lesions, Stent implants) for diagnosis, surgical planning, interventional procedures and treatment follow-up.
As with the FDA cleared 3D Angio software package(K984634), this software package will also assist the physician in diagnosis and treatment of vessel malformations(i.e. Aneurysms, AVMs and Stenoses).
Product codes
90JAA, JAK
Device Description
The In Space 3D package is a x-ray imaging software option which allows the reconstruction of two-dimensional images acquired with a standard angiographic C-arm device into a three-dimensional image format.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
x-ray
Anatomical Site
skeletal and soft tissue, internal body structures, vessel
Indicated Patient Age Range
Not Found
Intended User / Care Setting
physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Attachment 10
KOII447
510(k) Summary for the Siemens In Space 3D Software Option
Submitted by:
Siemens Medical Systems, Inc. 186 Wood Avenue South Iselin, NJ 08830
10 May, 2001
This 510(k) summary of safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
Contact Person: 1.
Mr. Praveen Nadkarni Phone: (732) 321-4950 Fax: (732) 321-4841
2. Device Name and Classification:
Trade Name: Classification Name: Classification Panel: CFR Section: Device Class: Product Code:
In Space 3D Software Option Accessory to Angiographic X-Ray System Radiology 21 CFR §892.1600 Class I.I. 90JAA
Substantial Equivalence: 3.
The In Space 3D software option is designed for three-dimensional evaluation of data acquired with a standard angiographic C-arm devices. The package is substantially equivalent to the following device:
| Device Name | FDA Clearance Number | FDA Clearance Date |
|---|---|---|
| 3D Angio Software Option | K984634 | 03/12/99 |
| Siemens Siremobil Iso C 3D Imaging Option | K003266 | 10/18/00 |
| Philips Integris 3D RA Option | K983877 | 12/21/98 |
1
4. Device Description:
The In Space 3D package is a x-ray imaging software option which allows the reconstruction of two-dimensional images acquired with a standard angiographic C-arm device into a three-dimensional image format.
ડ. Intended Use of the Device:
The In Space 3D package are intended to assist the physician in skeletal and soft tissue imaging in addition to the originally approved indications.
6. Summary of Technological Characteristics of the Devices Compared to the Predicate:
The Siemens In Space 3D software option and Philips Integris 3D-RA software allow construction of a three-dimensional model from two dimensional images acquired during rotational angiography.
Kathleen Rutherford
Kathleen Rutherford Manager, Regulatory Submissions Siemens Medical Systems, Inc.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing right, stacked on top of each other. The profiles are enclosed within a circular border, with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the upper half of the circle.
Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993
Mr. Praveen Nadkarni Technical Specialist Siemens Medical Systems, Inc. 186 Wood Avenue South ISELIN NJ 08830
AUG 2 3 2013
Re: K011447
Trade/Device Name: In Space 3D (Angiographic X-ray System Accessory) Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II Product Code: JAK Dated: May 10, 2001 Received: May 11, 2001
Dear Mr. Nadkarni:
This letter corrects our substantially equivalent letter of August 3, 2001.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Ilsting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Janine M. Morris
Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
Attachment 11
Indications For Use
510(k) Number (if known): ___________________________________________________________________________________________________________________________________________________ -----Device Name:
Indications For Use:
The In Space 3D package is a x-ray imaging software option which allows the reconstruction of two-dimensional images acquired with a standard angiographic C-arm device into a three-dimensional image format.
The In Space 3D package is intended for imaging both hard and soft tissues as well as other internal body structures(eg. Lesions, Stent implants) for diagnosis, surgical planning, interventional procedures and treatment follow-up.
As with the FDA cleared 3D Angio software package(K984634), this software package will also assist the physician in diagnosis and treatment of vessel malformations(i.e. Aneurysms, AVMs and Stenoses).
(Please do not write below this line - continue on another page if needed)
Concurrence of the CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
| 510(k) Number | K011447 |
|---|---|
| --------------- | --------- |
| Prescription Use | OR Over-The-Counter Use | |
|---|---|---|
| ------------------ | ----------------------------------------------------------- | ------------------------- |
(Per 21 CFR 801.109)